Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

10.0%

1 terminated/withdrawn out of 10 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
4(40.0%)
Phase 1
4(40.0%)
Phase 3
2(20.0%)
10Total
N/A(4)
Phase 1(4)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)